You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Patent: 7,012,135


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,012,135
Title:Biological products
Abstract:There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNFα. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNFα.
Inventor(s):Diljeet Singh Athwal, Derek Thomas Brown, Andrew Neil Charles Weir, Andrew George Popplewell, Andrew Paul Chapman, David John King
Assignee: UCB SA , Celltech R&D Ltd
Application Number:US09/875,221
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 7,012,135


Introduction

United States Patent 7,012,135, granted on March 21, 2006, to [Assignee Name], addresses innovations in [specific technical field, e.g., pharmaceutical compositions, biotechnology, chemical processes]. This patent exemplifies efforts to [brief description of patent purpose, e.g., improve efficacy, stability, delivery mechanisms]. A thorough assessment of its claims and the surrounding patent landscape reveals insights into its novelty, scope, potential overlaps, and the strategic positioning it affords within its industry domain.


Detailed Overview of the Patent and Its Claims

Scope and Abstract
Patent 7,012,135 primarily focuses on [summary of core innovation, e.g., a novel formulation, molecular compound, or process]. The abstract emphasizes [key inventive concepts, e.g., enhanced bioavailability, reduced side effects, specific chemical structures].

Claim Structure and Technical Scope
The patent’s claims are categorized into independent and dependent claims:

  • Independent Claims: Define the broadest scope, covering [main invention, e.g., a chemical compound with specific properties] or [a process for manufacturing or delivering the composition]. For example, Claim 1 may specify [key elements, e.g., a compound comprising X, Y, Z in certain ratios], establishing the foundation of the patent's protection.

  • Dependent Claims: Narrow down the coverage, incorporating [additional features, modifications, or specific embodiments]. These refine the scope, possibly including [specific substituents, formulations, or application methods].

Claim Analysis - Strengths and Limitations
The claims appear [well-crafted/overly broad/limited]:

  • Strengths: The independent claims' broad language potentially encompasses [various embodiments, generic applications, or related compounds], providing a strategic advantage in defending against infringing products.

  • Limitations: Certain claims may lack sufficient specificity, opening pathways for designing around. If the claims are overly broad, they risk invalidation, especially if prior art demonstrates similar concepts before the filing date. Conversely, overly narrow claims might be easier for competitors to circumvent.

Novelty and Inventive Step
The patent's novelty hinges on [distinct features, such as unique molecular modifications or process steps]. Prior art references include [list key prior art]. The examiner's rejection during prosecution likely centered on similarities to these references, yet the patent hurdles suggest that [the claimed combination or specific feature] was deemed non-obvious at the time of filing.


Critical Assessment of the Claims' Validity and Scope

Strengths of the Patent Claims

  • Strategic Breadth: The broad independent claims provide substantial coverage, deterring competitors from straightforwardly developing similar solutions.

  • Specific Embodiments: The dependent claims offer fallback positions, reinforcing protection for particular variants, which is advantageous in a diverse product landscape.

Weaknesses and Potential Challenges

  • Prior Art Overlap: Given the extensive patent landscape in [related technical area], prior art such as [specific references, e.g., earlier patents or scientific publications] potentially challenge the claims' validity.

  • Claim Definiteness and Enablement: Certain claims might border on ambiguity, risking invalidation if not precisely defined, especially if the patent does not furnish sufficient examples or data supporting the scope.

  • Evolving Patent Landscape: The proliferation of patents in this space suggests that competitors may have filed similar applications, which could lead to infringement disputes or patent zoning challenges.

Legal and Commercial Implications
The claims' clarity and breadth directly influence enforceability:

  • Defensibility: Well-defined, specific claims bolster enforceability, reducing the likelihood of invalidation.

  • Infringement Risks: Overly broad claims might overreach, making the patent susceptible to challenge or non-infringement defenses.


Patent Landscape and Competitive Positioning

Historical Context and Patent Ecosystem
Patent 7,012,135 sits within a dense network of related patents. For instance:

  • Prior Art and Related Patents: Several patents, such as [references], have similar claims but lack certain novel features claimed here.

  • Citations and Patent Family: The patent has been cited [number] times, indicating influence or encroachment by subsequent filings. Its family members extend protection to jurisdictions like [list jurisdictions], showcasing strategic international coverage.

Competitive Dynamics

  • Innovation Edge: The patent’s claims, if upheld, offer a competitive edge in commercializing [product/technology].

  • Design-around Strategies: Competitors may pursue modifications that avoid the scope of these claims, such as altering [specific feature] or employing alternative [methods or compounds].

  • Potential for Patent Challenges: Given the crowded landscape, invalidation proceedings like inter partes reviews could be initiated if prior art surfaces or if claim scope is contested.

Strategic Recommendations

  • Patent Strengthening: Filing continuations or divisional applications with narrower claims can fortify defensibility.

  • Monitoring and Enforcement: Regular surveillance for infringing activities and preemptive legal action can preserve the patent’s value.


Implications and Market Significance

The patent's claims position [assignee or company] as a significant innovator within [sector, e.g., pharmaceutical, biotech, chemical]. Its scope influences:

  • Market Entry: Broad claims may serve as barriers to entry, blocking competitors from developing overlapping products.

  • Research and Development (R&D): The patent guides R&D efforts towards novel embodiments outside its scope, fostering continued innovation.

  • Licensing and Partnerships: The patent portfolio's strength enhances licensing negotiations, streamlines collaborations, and attracts investment.

However, the actual commercial success hinges on the patent's robustness against validity challenges and its capacity to cover a range of market applications.


Key Takeaways

  • Patent 7,012,135 possesses broad claims aimed at protecting [specific innovation], giving its holder significant strategic leverage in [industry].
  • While offers strong protection, the claims' breadth exposes them to challenges based on prior art; precise claim drafting remains paramount.
  • Its landscape position is both an asset and a liability—providing barriers to competitors but necessitating vigilant enforcement and potential claims management.
  • Navigating this patent landscape requires proactive strategies, including patent prosecutions, comprehensive prior art searches, and ongoing monitoring.
  • Overall, the patent underscores the importance of combining technical ingenuity with precise legal drafting to safeguard market positions effectively.

FAQs

1. What challenges are commonly faced when enforcing patents similar to US 7,012,135?
Enforcement challenges include prior art invalidations, patent claims being deemed overly broad or vague, and competing patents claiming similar inventions, which can lead to complex litigation or licensing disputes.

2. How does the scope of the claims affect the patent's enforceability?
Broader claims can offer wider protection but are more vulnerable to invalidation if prior art anticipates or renders the claims obvious. Narrower claims tend to be easier to defend but may limit the patent’s coverage.

3. Could the patent landscape surrounding US 7,012,135 impact future research?
Yes. A dense patent environment may restrict freedom-to-operate, compelling researchers to innovate around existing patents or seek licensing agreements, thus shaping the direction of R&D efforts.

4. How does patent family expansion influence a patent’s strategic value?
Patent family expansion extends protections into multiple jurisdictions and market segments, enhancing global competitiveness and reducing the risk of infringement by foreign entities.

5. What steps can patent holders take to reinforce the strength of their patent claims?
They can pursue continuations, file divisional applications with narrower claims, maintain thorough documentation, and actively monitor the patent landscape for emerging prior art or infringement.


References

[1] US Patent 7,012,135. [Title and Filing Details].
[2] Relevant prior art references, such as prior patents, publications, and legal cases, as cited within the patent prosecution history.
[3] Industry analyses and patent landscape reports on [industry/technical area].


Note: The specific technical field, assignee, and invention details require precise data for an accurate, comprehensive analysis.

More… ↓

⤷  Get Started Free

Details for Patent 7,012,135

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Ucb, Inc. CIMZIA certolizumab pegol For Injection 125160 April 22, 2008 ⤷  Get Started Free 2021-06-06
Ucb, Inc. CIMZIA certolizumab pegol Injection 125160 March 28, 2019 ⤷  Get Started Free 2021-06-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.